{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T04:37:11Z","timestamp":1649133431353},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T00:00:00Z","timestamp":1489363200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s00115-017-0289-z","type":"journal-article","created":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T13:49:24Z","timestamp":1489412964000},"page":"365-372","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hilfreiche Zusatzuntersuchungen beim idiopathischen Parkinson-Syndrom"],"prefix":"10.1007","volume":"88","author":[{"given":"U.","family":"Walter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Zach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Liepelt-Scarfone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Maetzler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,13]]},"reference":[{"issue":"1","key":"289_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/ene.12022","volume":"20","author":"A Berardelli","year":"2013","unstructured":"Berardelli A, Wenning GK, Antonini A, Berg D, Bloem BR, Bonifati V, Brooks D, Burn DJ, Colosimo C, Fanciulli A, Ferreira J, Gasser T, Grandas F, Kanovsky P, Kostic V, Kulisevsky J, Oertel W, Poewe W, Reese JP, Relja M, Ruzicka E, Schrag A, Seppi K, Taba P, Vidailhet M (2013) EFNS\/MDS-ES\/ENS [corrected] recommendations for the diagnosis of Parkinson\u2019s disease. Eur J Neurol 20(1):16\u201334. doi: 10.1111\/ene.12022","journal-title":"Eur J Neurol"},{"key":"289_CR2","volume-title":"Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie: Idiopathisches Parkinson-Syndrom. Entwicklungsstufe: S3","author":"GOW Deuschl","year":"2016","unstructured":"Deuschl GOW, Reichmann H, Dams J, Dodel R (2016) Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie: Idiopathisches Parkinson-Syndrom. Entwicklungsstufe: S3. http:\/\/www.dgn.org\/images\/red_leitlinien\/LL_2016\/PDFs_Download\/030010_LL_langfassung_ips_2016.pdf . Zugegriffen: 01.01.2017"},{"issue":"12","key":"289_CR3","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/mds.26431","volume":"30","author":"D Berg","year":"2015","unstructured":"Berg D, Postuma RB, Adler CH, Bloem BR, Chan P, Dubois B, Gasser T, Goetz CG, Halliday G, Joseph L, Lang AE, Liepelt-Scarfone I, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, Poewe W, Stern M, Deuschl G (2015) MDS research criteria for prodromal Parkinson\u2019s disease. Mov Disord 30(12):1600\u20131611. doi: 10.1002\/mds.26431","journal-title":"Mov Disord"},{"issue":"5","key":"289_CR4","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1159\/000314495","volume":"7","author":"P Mahlknecht","year":"2010","unstructured":"Mahlknecht P, Hotter A, Hussl A, Esterhammer R, Schocke M, Seppi K (2010) Significance of MRI in diagnosis and differential diagnosis of Parkinson\u2019s disease. Neurodegener Dis 7(5):300\u2013318. doi: 10.1159\/000314495","journal-title":"Neurodegener Dis"},{"issue":"12","key":"289_CR5","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30(12):1591\u20131601. doi: 10.1002\/mds.26424","journal-title":"Mov Disord"},{"issue":"5","key":"289_CR6","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s00415-011-6280-x","volume":"259","author":"FJ Meijer","year":"2012","unstructured":"Meijer FJ, Aerts MB, Abdo WF, Prokop M, Borm GF, Esselink RA, Goraj B, Bloem BR (2012) Contribution of routine brain MRI to the differential diagnosis of parkinsonism: a\u00a03-year prospective follow-up study. J\u00a0Neurol 259(5):929\u2013935. doi: 10.1007\/s00415-011-6280-x","journal-title":"J Neurol"},{"issue":"2","key":"289_CR7","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s00415-014-7568-4","volume":"262","author":"MB Aerts","year":"2015","unstructured":"Aerts MB, Esselink RA, Abdo WF, Meijer FJ, Drost G, Norgren N, Janssen MJ, Borm GF, Bloem BR, Verbeek MM (2015) Ancillary investigations to diagnose parkinsonism: a\u00a0prospective clinical study. J\u00a0Neurol 262(2):346\u2013356. doi: 10.1007\/s00415-014-7568-4","journal-title":"J Neurol"},{"issue":"6","key":"289_CR8","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1212\/01.WNL.0000049911.91657.9D","volume":"60","author":"K Seppi","year":"2003","unstructured":"Seppi K, Schocke MF, Esterhammer R, Kremser C, Brenneis C, Mueller J, Boesch S, Jaschke W, Poewe W, Wenning GK (2003) Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy. Neurology 60(6):922\u2013927","journal-title":"Neurology"},{"issue":"7","key":"289_CR9","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00234-015-1515-7","volume":"57","author":"FJ Meijer","year":"2015","unstructured":"Meijer FJ, van Rumund A, Tuladhar AM, Aerts MB, Titulaer I, Esselink RA, Bloem BR, Verbeek MM, Goraj B (2015) Conventional 3T brain MRI and diffusion tensor imaging in the diagnostic workup of early stage parkinsonism. Neuroradiology 57(7):655\u2013669. doi: 10.1007\/s00234-015-1515-7","journal-title":"Neuroradiology"},{"issue":"Pt 2","key":"289_CR10","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/brain\/awv361","volume":"139","author":"PJ Planetta","year":"2016","unstructured":"Planetta PJ, Ofori E, Pasternak O, Burciu RG, Shukla P, DeSimone JC, Okun MS, McFarland NR, Vaillancourt DE (2016) Free-water imaging in Parkinson\u2019s disease and atypical Parkinsonism. Brain 139(Pt 2):495\u2013508. doi: 10.1093\/brain\/awv361","journal-title":"Brain"},{"issue":"16","key":"289_CR11","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1212\/01.wnl.0000340982.01727.6e","volume":"72","author":"DE Vaillancourt","year":"2009","unstructured":"Vaillancourt DE, Spraker MB, Prodoehl J, Abraham I, Corcos DM, Zhou XJ, Comella CL, Little DM (2009) High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology 72(16):1378\u20131384. doi: 10.1212\/01.wnl.0000340982.01727.6e","journal-title":"Neurology"},{"issue":"8","key":"289_CR12","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1002\/mds.26171","volume":"30","author":"E Reiter","year":"2015","unstructured":"Reiter E, Mueller C, Pinter B, Krismer F, Scherfler C, Esterhammer R, Kremser C, Schocke M, Wenning GK, Poewe W, Seppi K (2015) Dorsolateral nigral hyperintensity on 3.0T susceptibility-weighted imaging in neurodegenerative Parkinsonism. Mov Disord 30(8):1068\u20131076. doi: 10.1002\/mds.26171","journal-title":"Mov Disord"},{"issue":"6","key":"289_CR13","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1212\/WNL.0b013e31829e6fd2","volume":"81","author":"AI Blazejewska","year":"2013","unstructured":"Blazejewska AI, Schwarz ST, Pitiot A, Stephenson MC, Lowe J, Bajaj N, Bowtell RW, Auer DP, Gowland PA (2013) Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7\u202fT MRI. Neurology 81(6):534\u2013540. doi: 10.1212\/WNL.0b013e31829e6fd2","journal-title":"Neurology"},{"key":"289_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww278","author":"J Acosta-Cabronero","year":"2016","unstructured":"Acosta-Cabronero J, Cardenas-Blanco A, Betts MJ, Butryn M, Valdes-Herrera JP, Galazky I, Nestor PJ (2016) The whole-brain pattern of magnetic susceptibility perturbations in Parkinson\u2019s disease. Brain. doi: 10.1093\/brain\/aww278","journal-title":"Brain"},{"issue":"7","key":"289_CR15","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.parkreldis.2014.04.005","volume":"20","author":"C Ohtsuka","year":"2014","unstructured":"Ohtsuka C, Sasaki M, Konno K, Kato K, Takahashi J, Yamashita F, Terayama Y (2014) Differentiation of early-stage parkinsonisms using neuromelanin-sensitive magnetic resonance imaging. Parkinsonism Relat Disord 20(7):755\u2013760. doi: 10.1016\/j.parkreldis.2014.04.005","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"289_CR16","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/ene.12838","volume":"23","author":"S Reimao","year":"2016","unstructured":"Reimao S, Ferreira S, Nunes RG, Pita Lobo P, Neutel D, Abreu D, Goncalves N, Campos J, Ferreira JJ (2016) Magnetic resonance correlation of iron content with neuromelanin in the substantia nigra of early-stage Parkinson\u2019s disease. Eur J Neurol 23(2):368\u2013374. doi: 10.1111\/ene.12838","journal-title":"Eur J Neurol"},{"issue":"8","key":"289_CR17","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/mds.25087","volume":"27","author":"S Brodoehl","year":"2012","unstructured":"Brodoehl S, Klingner C, Volk GF, Bitter T, Witte OW, Redecker C (2012) Decreased olfactory bulb volume in idiopathic Parkinson\u2019s disease detected by 3.0-tesla magnetic resonance imaging. Mov Disord 27(8):1019\u20131025. doi: 10.1002\/mds.25087","journal-title":"Mov Disord"},{"issue":"7","key":"289_CR18","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1111\/ene.12709","volume":"22","author":"L Paschen","year":"2015","unstructured":"Paschen L, Schmidt N, Wolff S, Cnyrim C, van Eimeren T, Zeuner KE, Deuschl G, Witt K (2015) The olfactory bulb volume in patients with idiopathic Parkinson\u2019s disease. Eur J Neurol 22(7):1068\u20131073. doi: 10.1111\/ene.12709","journal-title":"Eur J Neurol"},{"issue":"7","key":"289_CR19","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.parkreldis.2015.05.001","volume":"21","author":"R Sengoku","year":"2015","unstructured":"Sengoku R, Matsushima S, Bono K, Sakuta K, Yamazaki M, Miyagawa S, Komatsu T, Mitsumura H, Kono Y, Kamiyama T, Ito K, Mochio S, Iguchi Y (2015) Olfactory function combined with morphology distinguishes Parkinson\u2019s disease. Parkinsonism Relat Disord 21(7):771\u2013777. doi: 10.1016\/j.parkreldis.2015.05.001","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"289_CR20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1586\/14737175.2016.1146590","volume":"16","author":"J Kassubek","year":"2016","unstructured":"Kassubek J, Muller HP (2016) Computer-based magnetic resonance imaging as a\u00a0tool in clinical diagnosis in neurodegenerative diseases. Expert Rev Neurother 16(3):295\u2013306. doi: 10.1586\/14737175.2016.1146590","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"289_CR21","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1212\/WNL.45.1.182","volume":"45","author":"G Becker","year":"1995","unstructured":"Becker G, Seufert J, Bogdahn U, Reichmann H, Reiners K (1995) Degeneration of substantia nigra in chronic Parkinson\u2019s disease visualized by transcranial color-coded real-time sonography. Neurology 45(1):182\u2013184","journal-title":"Neurology"},{"issue":"11","key":"289_CR22","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/S1474-4422(08)70239-4","volume":"7","author":"D Berg","year":"2008","unstructured":"Berg D, Godau J, Walter U (2008) Transcranial sonography in movement disorders. Lancet Neurol 7(11):1044\u20131055. doi: 10.1016\/S1474-4422(08)70239-4","journal-title":"Lancet Neurol"},{"issue":"2","key":"289_CR23","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/mds.25192","volume":"28","author":"D Berg","year":"2013","unstructured":"Berg D, Behnke S, Seppi K, Godau J, Lerche S, Mahlknecht P, Liepelt-Scarfone I, Pausch C, Schneider N, Gaenslen A, Brockmann K, Srulijes K, Huber H, Wurster I, Stockner H, Kiechl S, Willeit J, Gasperi A, Fassbender K, Gasser T, Poewe W (2013) Enlarged hyperechogenic substantia nigra as a\u00a0risk marker for Parkinson\u2019s disease. Mov Disord 28(2):216\u2013219. doi: 10.1002\/mds.25192","journal-title":"Mov Disord"},{"issue":"11","key":"289_CR24","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/S1474-4422(10)70216-7","volume":"9","author":"A Iranzo","year":"2010","unstructured":"Iranzo A, Lomena F, Stockner H, Valldeoriola F, Vilaseca I, Salamero M, Molinuevo JL, Serradell M, Duch J, Pavia J, Gallego J, Seppi K, Hogl B, Tolosa E, Poewe W, Santamaria J, Sleep Innsbruck Barcelona (SINBAR) group (2010) Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a\u00a0prospective study [corrected]. Lancet Neurol 9(11):1070\u20131077. doi: 10.1016\/S1474-4422(10)70216-7","journal-title":"Lancet Neurol"},{"issue":"4","key":"289_CR25","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1136\/jnnp-2011-301719","volume":"83","author":"K Busse","year":"2012","unstructured":"Busse K, Heilmann R, Kleinschmidt S, Abu-Mugheisib M, Hoppner J, Wunderlich C, Gemende I, Kaulitz L, Wolters A, Benecke R, Walter U (2012) Value of combined midbrain sonography, olfactory and motor function assessment in the differential diagnosis of early Parkinson\u2019s disease. J\u00a0Neurol Neurosurg Psychiatr 83(4):441\u2013447. doi: 10.1136\/jnnp-2011-301719","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"5","key":"289_CR26","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1111\/ene.12382","volume":"21","author":"A Gaenslen","year":"2014","unstructured":"Gaenslen A, Wurster I, Brockmann K, Huber H, Godau J, Faust B, Lerche S, Eschweiler GW, Maetzler W, Berg D (2014) Prodromal features for Parkinson\u2019s disease \u2013 baseline data from the TREND study. Eur J Neurol 21(5):766\u2013772. doi: 10.1111\/ene.12382","journal-title":"Eur J Neurol"},{"issue":"6","key":"289_CR27","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00702-014-1313-0","volume":"122","author":"U Walter","year":"2015","unstructured":"Walter U, Heilmann R, Kaulitz L, Just T, Krause BJ, Benecke R, Hoppner J (2015) Prediction of Parkinson\u2019s disease subsequent to severe depression: a\u00a0ten-year follow-up study. J\u00a0Neural Transm (Vienna) 122(6):789\u2013797. doi: 10.1007\/s00702-014-1313-0","journal-title":"J Neural Transm (Vienna)"},{"issue":"11","key":"289_CR28","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1001\/archneur.64.11.1635","volume":"64","author":"U Walter","year":"2007","unstructured":"Walter U, Dressler D, Probst T, Wolters A, Abu-Mugheisib M, Wittstock M, Benecke R (2007) Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease. Arch Neurol 64(11):1635\u20131640. doi: 10.1001\/archneur.64.11.1635","journal-title":"Arch Neurol"},{"issue":"5","key":"289_CR29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1474-4422(08)70067-X","volume":"7","author":"A Gaenslen","year":"2008","unstructured":"Gaenslen A, Unmuth B, Godau J, Liepelt I, Di Santo A, Schweitzer KJ, Gasser T, Machulla HJ, Reimold M, Marek K, Berg D (2008) The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson\u2019s disease: a\u00a0prospective blinded study. Lancet Neurol 7(5):417\u2013424. doi: 10.1016\/S1474-4422(08)70067-X","journal-title":"Lancet Neurol"},{"issue":"4","key":"289_CR30","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1055\/s-0033-1356415","volume":"35","author":"U Walter","year":"2014","unstructured":"Walter U, Skoloudik D (2014) Transcranial sonography (TCS) of brain parenchyma in movement disorders: quality standards, diagnostic applications and novel technologies. Ultraschall Med 35(4):322\u2013331. doi: 10.1055\/s-0033-1356415","journal-title":"Ultraschall Med"},{"issue":"11","key":"289_CR31","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.parkreldis.2013.06.019","volume":"19","author":"S Behnke","year":"2013","unstructured":"Behnke S, Hellwig D, Burmann J, Runkel A, Farmakis G, Kirsch CM, Fassbender K, Becker G, Dillmann U, Spiegel J (2013) Evaluation of transcranial sonographic findings and MIBG cardiac scintigraphy in the diagnosis of idiopathic Parkinson\u2019s disease. Parkinsonism Relat Disord 19(11):995\u2013999. doi: 10.1016\/j.parkreldis.2013.06.019","journal-title":"Parkinsonism Relat Disord"},{"issue":"11","key":"289_CR32","doi-asserted-by":"publisher","first-page":"e0165869","DOI":"10.1371\/journal.pone.0165869","volume":"11","author":"H Fujita","year":"2016","unstructured":"Fujita H, Suzuki K, Numao A, Watanabe Y, Uchiyama T, Miyamoto T, Miyamoto M, Hirata K (2016) Usefulness of cardiac MIBG scintigraphy, olfactory testing and substantia nigra hyperechogenicity as additional diagnostic markers for distinguishing between Parkinson\u2019s disease and atypical Parkinsonian syndromes. PLOS ONE 11(11):e0165869. doi: 10.1371\/journal.pone.0165869","journal-title":"PLOS ONE"},{"issue":"9","key":"289_CR33","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.ultrasmedbio.2007.03.013","volume":"33","author":"D Skoloudik","year":"2007","unstructured":"Skoloudik D, Fadrna T, Bartova P, Langova K, Ressner P, Zapletalova O, Hlustik P, Herzig R, Kannovsky P (2007) Reproducibility of sonographic measurement of the substantia nigra. Ultrasound Med Biol 33(9):1347\u20131352. doi: 10.1016\/j.ultrasmedbio.2007.03.013","journal-title":"Ultrasound Med Biol"},{"issue":"10","key":"289_CR34","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1136\/jnnp.2009.196352","volume":"81","author":"S Loo van de","year":"2010","unstructured":"van de Loo S, Walter U, Behnke S, Hagenah J, Lorenz M, Sitzer M, Hilker R, Berg D (2010) Reproducibility and diagnostic accuracy of substantia nigra sonography for the diagnosis of Parkinson\u2019s disease. J\u00a0Neurol Neurosurg Psychiatr 81(10):1087\u20131092. doi: 10.1136\/jnnp.2009.196352","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"3","key":"289_CR35","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00702-010-0469-5","volume":"118","author":"D Berg","year":"2011","unstructured":"Berg D (2011) Hyperechogenicity of the substantia nigra: pitfalls in assessment and specificity for Parkinson\u2019s disease. J\u00a0Neural Transm (Vienna) 118(3):453\u2013461. doi: 10.1007\/s00702-010-0469-5","journal-title":"J Neural Transm (Vienna)"},{"issue":"10","key":"289_CR36","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.7863\/ultra.32.10.1837","volume":"32","author":"U Walter","year":"2013","unstructured":"Walter U (2013) How to measure substantia nigra hyperechogenicity in Parkinson disease: detailed guide with video. J\u00a0Ultrasound Med 32(10):1837\u20131843. doi: 10.7863\/ultra.32.10.1837","journal-title":"J Ultrasound Med"},{"issue":"12","key":"289_CR37","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.3174\/ajnr.A4049","volume":"35","author":"D Skoloudik","year":"2014","unstructured":"Skoloudik D, Jelinkova M, Blahuta J, Cermak P, Soukup T, Bartova P, Langova K, Herzig R (2014) Transcranial sonography of the substantia nigra: digital image analysis. AJNR Am J Neuroradiol 35(12):2273\u20132278. doi: 10.3174\/ajnr.A4049","journal-title":"AJNR Am J Neuroradiol"},{"issue":"11","key":"289_CR38","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1007\/s00259-010-1520-3","volume":"37","author":"SJ Mo","year":"2010","unstructured":"Mo SJ, Linder J, Forsgren L, Larsson A, Johansson L, Riklund K (2010) Pre- and postsynaptic dopamine SPECT in the early phase of idiopathic parkinsonism: a\u00a0population-based study. Eur J Nucl Med Mol Imaging 37(11):2154\u20132164. doi: 10.1007\/s00259-010-1520-3","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"289_CR39","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.neuroimage.2005.03.012","volume":"26","author":"T Eckert","year":"2005","unstructured":"Eckert T, Barnes A, Dhawan V, Frucht S, Gordon MF, Feigin AS, Eidelberg D (2005) FDG PET in the differential diagnosis of parkinsonian disorders. Neuroimage 26(3):912\u2013921. doi: 10.1016\/j.neuroimage.2005.03.012","journal-title":"Neuroimage"},{"issue":"13","key":"289_CR40","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1212\/WNL.0b013e31826c1b0a","volume":"79","author":"S Hellwig","year":"2012","unstructured":"Hellwig S, Amtage F, Kreft A, Buchert R, Winz OH, Vach W, Spehl TS, Rijntjes M, Hellwig B, Weiller C, Winkler C, Weber WA, Tuscher O, Meyer PT (2012) [(1)(8)F]FDG-PET is superior to [(1)(2)(3)I]IBZM-SPECT for the differential diagnosis of Parkinsonism. Neurology 79(13):1314\u20131322. doi: 10.1212\/WNL.0b013e31826c1b0a","journal-title":"Neurology"},{"issue":"6","key":"289_CR41","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1007\/s00115-013-3995-1","volume":"85","author":"PT Meyer","year":"2014","unstructured":"Meyer PT, Amtage F, Hellwig S (2014) Differential diagnostics of Parkinson\u2019s disease with nuclear medicine procedures. Nervenarzt 85(6):680\u2013689. doi: 10.1007\/s00115-013-3995-1","journal-title":"Nervenarzt"},{"issue":"2","key":"289_CR42","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1136\/jnnp.2004.037028","volume":"76","author":"H Nagayama","year":"2005","unstructured":"Nagayama H, Hamamoto M, Ueda M, Nagashima J, Katayama Y (2005) Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson\u2019s disease. J\u00a0Neurol Neurosurg Psychiatr 76(2):249\u2013251. doi: 10.1136\/jnnp.2004.037028","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"2","key":"289_CR43","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00115-007-2326-9","volume":"79","author":"B Herting","year":"2008","unstructured":"Herting B, Bietenbeck S, Scholz K, Hahner A, Hummel T, Reichmann H (2008) Olfactory dysfunction in Parkinson\u2019s disease: its role as a\u00a0new cardinal sign in early and differential diagnosis. Nervenarzt 79(2):175\u2013184. doi: 10.1007\/s00115-007-2326-9","journal-title":"Nervenarzt"},{"issue":"4","key":"289_CR44","doi-asserted-by":"publisher","first-page":"365","DOI":"10.7861\/clinmedicine.16-4-365","volume":"16","author":"A Sauerbier","year":"2016","unstructured":"Sauerbier A, Qamar MA, Rajah T, Chaudhuri KR (2016) New concepts in the pathogenesis and presentation of Parkinson\u2019s disease. Clin Med (Lond) 16(4):365\u2013370. doi: 10.7861\/clinmedicine.16-4-365","journal-title":"Clin Med (Lond)"},{"issue":"Pt 1","key":"289_CR45","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1093\/brain\/awv251","volume":"139","author":"K Doppler","year":"2016","unstructured":"Doppler K, Volkmann J, Sommer C (2016) Skin biopsies in the differential diagnosis of parkinsonism: are we ready for simplified protocols? Brain 139(Pt 1):e5. doi: 10.1093\/brain\/awv251","journal-title":"Brain"},{"issue":"2","key":"289_CR46","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3233\/JPD-150740","volume":"6","author":"JM Uem van","year":"2016","unstructured":"van Uem JM, Isaacs T, Lewin A, Bresolin E, Salkovic D, Espay AJ, Matthews H, Maetzler W (2016) A viewpoint on wearable technology-enabled measurement of wellbeing and health-related quality of life in Parkinson\u2019s disease. J\u00a0Parkinsons Dis 6(2):279\u2013287. doi: 10.3233\/JPD-150740","journal-title":"J Parkinsons Dis"},{"issue":"6","key":"289_CR47","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1002\/mds.23572","volume":"26","author":"M Hallett","year":"2011","unstructured":"Hallett M, Rothwell J (2011) Milestones in clinical neurophysiology. Mov Disord 26(6):958\u2013967. doi: 10.1002\/mds.23572","journal-title":"Mov Disord"},{"issue":"9","key":"289_CR48","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1002\/mds.26676","volume":"31","author":"JM Uem van","year":"2016","unstructured":"van Uem JM, Maier KS, Hucker S, Scheck O, Hobert MA, Santos AT, Fagerbakke O, Larsen F, Ferreira JJ, Maetzler W (2016) Twelve-week sensor assessment in Parkinson\u2019s disease: Impact on quality of life. Mov Disord 31(9):1337\u20131338. doi: 10.1002\/mds.26676","journal-title":"Mov Disord"},{"issue":"4","key":"289_CR49","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1586\/14737167.8.4.401","volume":"8","author":"P Martinez-Martin","year":"2008","unstructured":"Martinez-Martin P, Rodriguez-Blazquez C, Frades-Payo B (2008) Specific patient-reported outcome measures for Parkinson\u2019s disease: analysis and applications. Expert Rev Pharmacoecon Outcomes Res 8(4):401\u2013418. doi: 10.1586\/14737167.8.4.401","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"1","key":"289_CR50","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s100720170066","volume":"22","author":"C Vitale","year":"2001","unstructured":"Vitale C, Pellecchia MT, Grossi D, Fragassi N, Cuomo T, Di Maio L, Barone P (2001) Unawareness of dyskinesias in Parkinson\u2019s and Huntington\u2019s diseases. Neurol Sci 22(1):105\u2013106","journal-title":"Neurol. Sci."},{"key":"289_CR51","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.bandc.2016.01.006","volume":"103","author":"S Parveen","year":"2016","unstructured":"Parveen S (2016) Comparison of self and proxy ratings for motor performance of individuals with Parkinson disease. Brain Cogn 103:62\u201369. doi: 10.1016\/j.bandc.2016.01.006","journal-title":"Brain Cogn"},{"issue":"1","key":"289_CR52","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/mdc3.12207","volume":"3","author":"ED Louis","year":"2015","unstructured":"Louis ED (2015) More time with tremor: the experience of essential tremor versus Parkinson\u2019s disease patients. Mov Disord Clin Pract 3(1):36\u201342. doi: 10.1002\/mdc3.12207","journal-title":"Mov Disord Clin Pract"},{"key":"289_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2016.11.015","author":"H Zach","year":"2016","unstructured":"Zach H, Dirkx M, Pasman JW, Bloem BR, Helmich RC (2016) The patient\u2019s perspective: the effect of levodopa on Parkinson symptoms. Parkinsonism Relat Disord. doi: 10.1016\/j.parkreldis.2016.11.015","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-017-0289-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-017-0289-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-017-0289-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T12:31:46Z","timestamp":1498393906000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-017-0289-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,13]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["289"],"URL":"https:\/\/doi.org\/10.1007\/s00115-017-0289-z","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,13]]}}}